Mammalian target of rapamycin inhibitors, temsirolimus and torin 1, attenuate stemness-associated properties and expression of mesenchymal markers promoted by phorbol-myristate-acetate and oncostatin-M in glioblastoma cells
The phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathway is crucial for tumor survival, proliferation, and progression, making it an attractive target for therapeutic intervention. In glioblastoma, activated mammalian target of rapamycin promotes invasive phenotype and c...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-03-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317695921 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849417140772274176 |
|---|---|
| author | Goparaju Chandrika Kumar Natesh Deepak Ranade Ashish Chugh Padma Shastry |
| author_facet | Goparaju Chandrika Kumar Natesh Deepak Ranade Ashish Chugh Padma Shastry |
| author_sort | Goparaju Chandrika |
| collection | DOAJ |
| description | The phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathway is crucial for tumor survival, proliferation, and progression, making it an attractive target for therapeutic intervention. In glioblastoma, activated mammalian target of rapamycin promotes invasive phenotype and correlates with poor patient survival. A wide range of mammalian target of rapamycin inhibitors are currently being evaluated for cytotoxicity and anti-proliferative activity in various tumor types but are not explored sufficiently for controlling tumor invasion and recurrence. We recently reported that mammalian target of rapamycin inhibitors—rapamycin, temsirolimus, torin 1, and PP242—suppressed invasion and migration promoted by tumor necrosis factor-alpha and phorbol-myristate-acetate in glioblastoma cells. As aggressive invasion and migration of tumors are associated with mesenchymal and stem-like cell properties, this study aimed to examine the effect of mammalian target of rapamycin inhibitors on these features in glioblastoma cells. We demonstrate that temsirolimus and torin 1 effectively reduced the constitutive as well as phorbol-myristate-acetate/oncostatin-M-induced expression of mesenchymal markers (fibronectin, vimentin, and YKL40) and neural stem cell markers (Sox2, Oct4, nestin, and mushashi1). The inhibitors significantly abrogated the neurosphere-forming capacity induced by phorbol-myristate-acetate and oncostatin-M. Furthermore, we demonstrate that the drugs dephosphorylated signal transducer and activator transcription factor 3, a major regulator of mesenchymal and neural stem cell markers implicating the role of signal transducer and activator transcription factor 3 in the inhibitory action of these drugs. The findings demonstrate the potential of mammalian target of rapamycin inhibitors as “stemness-inhibiting drugs” and a promising therapeutic approach to target glioma stem cells. |
| format | Article |
| id | doaj-art-0cff7bd8a78d4765a67f6e961954fe22 |
| institution | Kabale University |
| issn | 1423-0380 |
| language | English |
| publishDate | 2017-03-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Tumor Biology |
| spelling | doaj-art-0cff7bd8a78d4765a67f6e961954fe222025-08-20T03:32:57ZengSAGE PublishingTumor Biology1423-03802017-03-013910.1177/1010428317695921Mammalian target of rapamycin inhibitors, temsirolimus and torin 1, attenuate stemness-associated properties and expression of mesenchymal markers promoted by phorbol-myristate-acetate and oncostatin-M in glioblastoma cellsGoparaju Chandrika0Kumar Natesh1Deepak Ranade2Ashish Chugh3Padma Shastry4National Centre for Cell Science (NCCS), Savitribai Phule Pune University, Pune, IndiaNational Centre for Cell Science (NCCS), Savitribai Phule Pune University, Pune, IndiaDepartment of Neurosurgery, D. Y. Patil Medical College, Hospital & Research Centre, Pune, IndiaDepartment of Neurosurgery, CIMET’s Inamdar Multispecialty Hospital, Pune, IndiaNational Centre for Cell Science (NCCS), Savitribai Phule Pune University, Pune, IndiaThe phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling pathway is crucial for tumor survival, proliferation, and progression, making it an attractive target for therapeutic intervention. In glioblastoma, activated mammalian target of rapamycin promotes invasive phenotype and correlates with poor patient survival. A wide range of mammalian target of rapamycin inhibitors are currently being evaluated for cytotoxicity and anti-proliferative activity in various tumor types but are not explored sufficiently for controlling tumor invasion and recurrence. We recently reported that mammalian target of rapamycin inhibitors—rapamycin, temsirolimus, torin 1, and PP242—suppressed invasion and migration promoted by tumor necrosis factor-alpha and phorbol-myristate-acetate in glioblastoma cells. As aggressive invasion and migration of tumors are associated with mesenchymal and stem-like cell properties, this study aimed to examine the effect of mammalian target of rapamycin inhibitors on these features in glioblastoma cells. We demonstrate that temsirolimus and torin 1 effectively reduced the constitutive as well as phorbol-myristate-acetate/oncostatin-M-induced expression of mesenchymal markers (fibronectin, vimentin, and YKL40) and neural stem cell markers (Sox2, Oct4, nestin, and mushashi1). The inhibitors significantly abrogated the neurosphere-forming capacity induced by phorbol-myristate-acetate and oncostatin-M. Furthermore, we demonstrate that the drugs dephosphorylated signal transducer and activator transcription factor 3, a major regulator of mesenchymal and neural stem cell markers implicating the role of signal transducer and activator transcription factor 3 in the inhibitory action of these drugs. The findings demonstrate the potential of mammalian target of rapamycin inhibitors as “stemness-inhibiting drugs” and a promising therapeutic approach to target glioma stem cells.https://doi.org/10.1177/1010428317695921 |
| spellingShingle | Goparaju Chandrika Kumar Natesh Deepak Ranade Ashish Chugh Padma Shastry Mammalian target of rapamycin inhibitors, temsirolimus and torin 1, attenuate stemness-associated properties and expression of mesenchymal markers promoted by phorbol-myristate-acetate and oncostatin-M in glioblastoma cells Tumor Biology |
| title | Mammalian target of rapamycin inhibitors, temsirolimus and torin 1, attenuate stemness-associated properties and expression of mesenchymal markers promoted by phorbol-myristate-acetate and oncostatin-M in glioblastoma cells |
| title_full | Mammalian target of rapamycin inhibitors, temsirolimus and torin 1, attenuate stemness-associated properties and expression of mesenchymal markers promoted by phorbol-myristate-acetate and oncostatin-M in glioblastoma cells |
| title_fullStr | Mammalian target of rapamycin inhibitors, temsirolimus and torin 1, attenuate stemness-associated properties and expression of mesenchymal markers promoted by phorbol-myristate-acetate and oncostatin-M in glioblastoma cells |
| title_full_unstemmed | Mammalian target of rapamycin inhibitors, temsirolimus and torin 1, attenuate stemness-associated properties and expression of mesenchymal markers promoted by phorbol-myristate-acetate and oncostatin-M in glioblastoma cells |
| title_short | Mammalian target of rapamycin inhibitors, temsirolimus and torin 1, attenuate stemness-associated properties and expression of mesenchymal markers promoted by phorbol-myristate-acetate and oncostatin-M in glioblastoma cells |
| title_sort | mammalian target of rapamycin inhibitors temsirolimus and torin 1 attenuate stemness associated properties and expression of mesenchymal markers promoted by phorbol myristate acetate and oncostatin m in glioblastoma cells |
| url | https://doi.org/10.1177/1010428317695921 |
| work_keys_str_mv | AT goparajuchandrika mammaliantargetofrapamycininhibitorstemsirolimusandtorin1attenuatestemnessassociatedpropertiesandexpressionofmesenchymalmarkerspromotedbyphorbolmyristateacetateandoncostatinminglioblastomacells AT kumarnatesh mammaliantargetofrapamycininhibitorstemsirolimusandtorin1attenuatestemnessassociatedpropertiesandexpressionofmesenchymalmarkerspromotedbyphorbolmyristateacetateandoncostatinminglioblastomacells AT deepakranade mammaliantargetofrapamycininhibitorstemsirolimusandtorin1attenuatestemnessassociatedpropertiesandexpressionofmesenchymalmarkerspromotedbyphorbolmyristateacetateandoncostatinminglioblastomacells AT ashishchugh mammaliantargetofrapamycininhibitorstemsirolimusandtorin1attenuatestemnessassociatedpropertiesandexpressionofmesenchymalmarkerspromotedbyphorbolmyristateacetateandoncostatinminglioblastomacells AT padmashastry mammaliantargetofrapamycininhibitorstemsirolimusandtorin1attenuatestemnessassociatedpropertiesandexpressionofmesenchymalmarkerspromotedbyphorbolmyristateacetateandoncostatinminglioblastomacells |